P Praveen Singh π Tutor III β 36.81K Points π Current Advances of Novel Drug Delivery System Q. In the use of TDDS for drug application ? size has to be considered reasonable? (A) Strip size (B) Patch size (C) Film size (D) Diskette size ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Patch size
V Vinay π Mover β 28.75K Points π Current Advances of Novel Drug Delivery System Q. TDDS is usually only suitable for drugs of what level of potency? (A) Typically only for drugs of high potency. (B) Low potency (C) High to low potency (D) Low to high potency ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Typically only for drugs of high potency.
R Ranjeet π Tutor III β 34.60K Points π Current Advances of Novel Drug Delivery System Q. How much thickness of the dermis layer? (A) 2 to 7 nm (B) 3 to 5 nm (C) 3 to 6 nm (D) 5 to 8 nm ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) 3 to 5 nm
P Praveen Singh π Tutor III β 36.81K Points π Current Advances of Novel Drug Delivery System Q. Regarding the skin: (A) The epidermis is the thickest layer. (B) The stratum corneum is the greatest barrier to transdermal transport. (C) The dermis has a rich capillary blood supply. (D) Skin hydration is a cause of inter-individual variation in drug absorption. ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Skin hydration is a cause of inter-individual variation in drug absorption.
V Vinay π Mover β 28.75K Points π Current Advances of Novel Drug Delivery System Q. Problems with opioid TDDS include. (A) Poor patient compliance (B) Allergy (C) Constipation. (D) Respiratory depression. ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Allergy
P Praveen Singh π Tutor III β 36.81K Points π Current Advances of Novel Drug Delivery System Q. Which of the following is false for monolithic devices? (A) The drug used for these devices has large therapeutic index (B) There are three categories of matrix devices (C) 1st type has the drug dissolved in the polymer matrix (D) 2nd type has drug delivery ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) There are three categories of matrix devices
R Ranjeet π Tutor III β 34.60K Points π Current Advances of Novel Drug Delivery System Q. The absorption of the ophthalmic drug does not depend on which of the following? (A) Physicochemical properties of permeating molecule (B) Drainage of tears (C) Output of tears (D) Size of the eyeball ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Size of the eyeball
A Admin π Coach β 38.23K Points π Current Advances of Novel Drug Delivery System Q. Which of the following is true for monolithic devices? (A) These devices are used when the drug permeation rate is rapid (B) The release of the drug is controlled (C) Suitable for drugs with large therapeutic index (D) The drug is contained in a powder form floating on liquid ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) Suitable for drugs with large therapeutic index
R Ram Sharma π Coach β 193.88K Points π Current Advances of Novel Drug Delivery System Q. Which of the following is false in regarding reservoir devices? (A) These devices are used when the drug permeation rate is rapid (B) The release of the drug is controlled (C) Suitable for low therapeutic index (D) The drug is contained in a powder from floating on liquid ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) The drug is contained in a powder from floating on liquid
R Ranjeet π Tutor III β 34.60K Points π Current Advances of Novel Drug Delivery System Q. What are the characteristics of the mixed monolithic reservoir devices? (A) The drug has a large therapeutic index (B) Drug permeation rate is high (C) The drug polymer matrix is layered by rate controlling membrane (D) Administration of emulsion ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) The drug polymer matrix is layered by rate controlling membrane